359090 — C&R Research Income Statement
0.000.00%
Last trade - 00:00- KR₩82bn
- KR₩77bn
- KR₩55bn
- 53
- 49
- 49
- 49
Annual income statement for C&R Research, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 7 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 43,171 | 48,498 | 55,102 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 28.6 | 37,358 | 43,863 | 48,800 |
| Operating Profit | -28.6 | 5,813 | 4,635 | 6,302 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -21.7 | -2,724 | 4,091 | 5,791 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -19.3 | -3,304 | 3,928 | 5,547 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | -19.3 | -3,301 | 3,929 | 5,563 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -19.3 | -3,301 | 3,929 | 5,563 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -4.58 | -62.9 | 74.5 | 98.6 |
| Dividends per Share |